专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US4917885A Hard medicinal capsule 失效
标题翻译：硬药胶囊
公开(公告)号：US4917885A
公开(公告)日：1990-04-17
申请号：US946119
申请日：1986-12-23
申请人： Tohru Chiba , Hiroaki Muto , Soji Tanioka , Yuichi Nishiyama , Noboru Hoshi , Yoshiro Onda
发明人： Tohru Chiba , Hiroaki Muto , Soji Tanioka , Yuichi Nishiyama , Noboru Hoshi , Yoshiro Onda
IPC分类号： A61K9/48 , C08L1/28
CPC分类号： A61K9/4816 , C08L1/28
摘要： In place of gelatin conventionally used as a material for shaping hard medicinal capsules, the invention proposes a hard capsule for medicinal use shaped of a polymer blend of a water-soluble cellulose ether, e.g., alkyl cellulose, hydroxyalkyl cellulose and alkyl hydroxyalkyl cellulose, and a polyvinyl alcohol in a weight ratio of 70:30 to 98:2. The inventive hard medicinal capsules have remarkably low permeability to oxygen and moisture with little influences on the medicament contained therein along with sufficiently high mechanical strengths and are much more stable than conventional gelatin-made capsules against the influences of the ambient conditions, such as, the crack formation unavoidable in a gelatin-made hard capsule when it is kept under an extremely low humidity.
摘要翻译：本发明代替通常用作形成硬药胶囊的材料的明胶，而提出了一种用于医用的硬胶囊，其形式为水溶性纤维素醚，例如烷基纤维素，羟烷基纤维素和烷基羟烷基纤维素的聚合物共混物，以及聚乙烯醇，重量比为70:30至98:2。本发明的硬药物胶囊具有非常低的氧气和水分渗透性，对其中所含的药物几乎没有影响，同时具有足够高的机械强度，并且比常规明胶制成的胶囊比环境条件的影响更稳定，例如当明胶制成的硬胶囊保持在极低的湿度下时，不可避免的裂缝形成。

2. 发明授权

US3957523A Coating compositions for solid medicines 失效
标题翻译：固体药物涂料组合物
公开(公告)号：US3957523A
公开(公告)日：1976-05-18
申请号：US455533
申请日：1974-03-28
申请人： Shigeru Ohno , Noboru Hoshi , Fujio Sekigawa
发明人： Shigeru Ohno , Noboru Hoshi , Fujio Sekigawa
IPC分类号： A61K47/38 , A61K9/28 , A61K9/30 , A61K9/36 , A61K9/50 , C08L1/12 , C08L1/26
CPC分类号： A61K9/5042 , A61K9/2866 , A61K9/5047
摘要： When a mixture comprising 30 to 70% by weight of an enterosoluble cellulose derivative containing a monoester linkage with a polybasic acid, such as, hydroxypropyl methylcellulose phthalate, and 70 to 30% by weight of a digestive fluid-insoluble cellulose derivative, such as, ethylcellulose is used as a coating material for solid medicines, the rate of gradual release of active ingredients of the medicine in the intestinal tracts can be appropriately controlled.
摘要翻译：含有30〜70重量％含有与多元酸的单酯键的羟基丙基甲基纤维素邻苯二甲酸酯和70〜30重量％的消化不溶性纤维素衍生物的肠溶性纤维素衍生物的混合物，乙基纤维素用作固体药物的涂层材料，可以适当地控制药物在肠道中的活性成分的逐渐释放的速率。

3. 发明授权

US08552102B2 Coating composition 有权
标题翻译：涂料组成
公开(公告)号：US08552102B2
公开(公告)日：2013-10-08
申请号：US13600879
申请日：2012-08-31
申请人： Makoto Noami , Toshiro Fujii , Yoshihiro Furuya , Noboru Hoshi , Toshio Shimamoto , Shunji Uramatsu
发明人： Makoto Noami , Toshiro Fujii , Yoshihiro Furuya , Noboru Hoshi , Toshio Shimamoto , Shunji Uramatsu
IPC分类号： C08F8/00
CPC分类号： A61K9/5026 , A23P20/19 , A61K9/2027 , A61K9/284 , A61K9/5073 , Y10T428/2991 , Y10T428/2998
摘要： The present invention relates to a novel resin composition useful as a coating agent or a binder for medicines, drugs for animals, agricultural chemicals, fertilizers, foods or the like, which contains a polyvinyl alcohol copolymer as a main component. More particularly, the present invention relates to a resin composition, characterized in that the composition is obtained by copolymerizing a polyvinyl alcohol having an average polymerization degree of 1300 or less, and at least one polymerizable vinyl monomer in a weight ratio of 6:4 to 9:1.
摘要翻译：本发明涉及以聚乙烯醇共聚物为主要成分的用作药物，动物用药物，农药，肥料，食品等的包衣剂或粘合剂的新型树脂组合物。更具体地说，本发明涉及一种树脂组合物，其特征在于，所述组合物通过使平均聚合度为1300以下的聚乙烯醇与至少一种重量比为6:4的可聚合乙烯基单体共聚而获得， 9：1。

4. 发明授权

US4405597A Medicament capsules for rectal application 失效
标题翻译：用于直肠应用的药物胶囊
公开(公告)号：US4405597A
公开(公告)日：1983-09-20
申请号：US292040
申请日：1981-08-11
申请人： Yasushi Takagishi , Yoshio Doi , Kiichiro Ohsuga , Noboru Hoshi , Shionogi & Co., Ltd.
发明人： Yasushi Takagishi , Yoshio Doi , Kiichiro Ohsuga , Noboru Hoshi , Shionogi & Co., Ltd.
IPC分类号： A61K9/02 , A61K9/36 , A61K9/48
CPC分类号： A61K9/4816 , A61K9/025
摘要： The invention provides a novel means for the administration of a therapeutically effective ingredient in the form of a rectally applicable medicament capsule, in which the otherwise unavoidable extreme variation in the absorbability of the effective ingredient among the individuals rectally treated with the capsules is minimized. It has been unexpectedly found that, when the effective ingredient is contained in the capsule in the form of a liquid medicine, the osmotic pressure of the liquid content plays a very essential role in the absorption of the effective ingredient through the rectum and the variation in the absorbability of the effective ingredient among the individuals can be minimized when the osmotic pressure of the liquid content is substantially higher than the osmotic pressure of the rectal fluid with which the capsules are contacted.
摘要翻译：本发明提供了一种用于施用直肠可用药物胶囊形式的治疗有效成分的新方法，其中用胶囊直肠治疗的个体之间有效成分的吸收性的其他不可避免的极端变化最小化。已经意外地发现，当液体药物形式的胶囊中含有有效成分时，液体含量的渗透压在通过直肠的有效成分的吸收中发挥非常重要的作用，当液体含量的渗透压显着高于胶囊与其接触的直肠液的渗透压时，个体之间有效成分的吸收能力可被最小化。

5. 发明申请

US20050186268A1 Hard capsule 审中-公开
标题翻译：硬胶囊
公开(公告)号：US20050186268A1
公开(公告)日：2005-08-25
申请号：US11110428
申请日：2005-04-20
申请人： Noboru Hoshi , Toshio Shimamoto , Shigeru Sugiyama
发明人： Noboru Hoshi , Toshio Shimamoto , Shigeru Sugiyama
IPC分类号： A61J3/07 , A61K9/48 , A61K47/32 , B01J13/02 , B01J13/04
CPC分类号： A61K47/32 , A61J3/071 , A61K9/4816 , Y10S514/962 , Y10T428/1352
摘要： A method of manufacturing a hard capsule made mainly of a polymer or copolymer obtained includes polymerizing or copolymerizing at least one polymerizable vinyl monomer in the presence of polyvinyl alcohol and/or a derivative thereof. Unlike conventional hard capsules, this hard capsule can be filled with a solvent (e.g., polyethylene glycol) for a sparingly soluble drug ingredient.
摘要翻译：主要由聚合物或共聚物制成的硬胶囊的制造方法包括在聚乙烯醇和/或其衍生物的存在下聚合或共聚至少一种可聚合的乙烯基单体。与常规的硬胶囊不同，该硬胶囊可以填充溶剂（例如，聚乙二醇），用于微溶药物成分。

6. 发明授权

US4402692A Medicament capsules for rectal application 失效
标题翻译：用于直肠应用的药物胶囊
公开(公告)号：US4402692A
公开(公告)日：1983-09-06
申请号：US269706
申请日：1981-06-02
申请人： Yasushi Takagishi , Yoshio Doi , Kanji Aita , Noboru Hoshi
发明人： Yasushi Takagishi , Yoshio Doi , Kanji Aita , Noboru Hoshi
IPC分类号： A61K31/48 , A61K9/02 , A61K9/48 , A61M7/00
CPC分类号： A61K9/025 , A61K9/4816 , Y10S514/962
摘要： The invention provides a novel and efficient means for the administration of a therapeutically effective ingredient by rectal application in the form of a medicament capsule encapsulating the effective ingredient. The medicament capsule according to the invention is formed of a hard capsule shell made of a mixed ester of a cellulose ether, e.g. alkyl-, hydroxyalkyl- and hydroxyalkyl alkylcelluloses, esterified with aliphatic monacyl groups and acidic succinyl groups. When the capsule is inserted into the rectum, the capsule shell is disintegrated and the rectally absorbable effective ingredient is readily and smoothly released into the rectum and absorbed to exhibit therapeutical effects as efficiently as with conventional suppositories.
摘要翻译：本发明提供了一种用于通过直肠施用以包封有效成分的药物胶囊的形式施用治疗有效成分的新型和有效的方法。根据本发明的药物胶囊由纤维素醚混合酯制成的硬胶囊壳形成。烷基，羟基烷基和羟烷基烷基纤维素，用脂族单酰基和酸性琥珀酰基酯化。当胶囊插入直肠时，胶囊壳崩解，直肠可吸收的有效成分容易平稳地释放到直肠中并被吸收以显示与常规栓剂一样有效的治疗效果。

7. 发明授权

US4397835A Enterosoluble hard-capsulated medicaments 失效
公开(公告)号：US4397835A
公开(公告)日：1983-08-09
申请号：US372791
申请日：1982-04-28
申请人： Yasushi Takagishi , Yoshio Doi , Noboru Hoshi
发明人： Yasushi Takagishi , Yoshio Doi , Noboru Hoshi
IPC分类号： A61K9/48
CPC分类号： A61K9/4858 , A61K9/4816 , A61K9/485
摘要： The invention provides a novel means for overcoming the problem of undue and irregular delay in the exhibition of the effect of medicine when a patient is administrated with an enterosoluble hard-capsulated medicament. The unexpected discovery that the key parameter ruling the smooth transfer of an enterosoluble capsule from the stomach to the intestinal canals is the overall specific gravity of the capsule has led to the establishment of the invention which proposes an enterosoluble hard-capsulated medicament having an overall specific gravity of at least 1.05 or, preferably, at least 1.10.

8. 发明授权

US08277844B2 Coating composition 有权
标题翻译：涂料组成
公开(公告)号：US08277844B2
公开(公告)日：2012-10-02
申请号：US10567739
申请日：2004-08-05
申请人： Makoto Noami , Toshiro Fujii , Yoshihiro Furuya , Noboru Hoshi , Toshio Shimamoto , Shunji Uramatsu
发明人： Makoto Noami , Toshiro Fujii , Yoshihiro Furuya , Noboru Hoshi , Toshio Shimamoto , Shunji Uramatsu
IPC分类号： A61K9/32 , B32B5/16
CPC分类号： A61K9/5026 , A23P20/19 , A61K9/2027 , A61K9/284 , A61K9/5073 , Y10T428/2991 , Y10T428/2998
摘要： The present invention relates to a novel resin composition useful as a coating agent or a binder for medicines, drugs for animals, agricultural chemicals, fertilizers, foods or the like, which contains a polyvinyl alcohol copolymer as a main component. More particularly, the present invention relates to a resin composition, characterized in that the composition is obtained by copolymerizing a polyvinyl alcohol having an average polymerization degree of 1300 or less, and at least one polymerizable vinyl monomer in a weight ratio of 6:4 to 9:1.
摘要翻译：本发明涉及以聚乙烯醇共聚物为主要成分的用作药物，动物用药物，农药，肥料，食品等的包衣剂或粘合剂的新型树脂组合物。更具体地说，本发明涉及一种树脂组合物，其特征在于，所述组合物通过使平均聚合度为1300以下的聚乙烯醇与至少一种重量比为6:4的可聚合乙烯基单体共聚而获得， 9：1。

9. 发明申请

US20060229383A1 Novel coating composition 有权
标题翻译：新型涂料组合物
公开(公告)号：US20060229383A1
公开(公告)日：2006-10-12
申请号：US10567739
申请日：2004-08-05
申请人： Makoto Noami , Toshiro Fujii , Yoshihiro Furuya , Noboru Hoshi , Toshio Shimamoto , Shunji Uramatsu
发明人： Makoto Noami , Toshiro Fujii , Yoshihiro Furuya , Noboru Hoshi , Toshio Shimamoto , Shunji Uramatsu
IPC分类号： C03C17/00
CPC分类号： A61K9/5026 , A23P20/19 , A61K9/2027 , A61K9/284 , A61K9/5073 , Y10T428/2991 , Y10T428/2998
摘要： The present invention relates to a novel resin composition useful as a coating agent or a binder for medicines, drugs for animals, agricultural chemicals, fertilizers, foods or the like, which contains a polyvinyl alcohol copolymer as a main component. More particularly, the present invention relates to a resin composition, characterized in that the composition is obtained by copolymerizing a polyvinyl alcohol having an average polymerization degree of 1300 or less, and at least one polymerizable vinyl monomer in a weight ratio of 6:4 to 9:1.
摘要翻译：本发明涉及以聚乙烯醇共聚物为主要成分的用作药物，动物用药物，农药，肥料，食品等的包衣剂或粘合剂的新型树脂组合物。更具体地说，本发明涉及一种树脂组合物，其特征在于，所述组合物通过使平均聚合度为1300以下的聚乙烯醇与至少一种重量比为6:4的可聚合乙烯基单体共聚而获得， 9：1。

10. 发明授权

US4339463A Enterosoluble hard-capsulated medicaments 失效
标题翻译：肠溶性硬封闭药物
公开(公告)号：US4339463A
公开(公告)日：1982-07-13
申请号：US169395
申请日：1980-07-16
申请人： Yasushi Takagishi , Yoshio Doi , Noboru Hoshi
发明人： Yasushi Takagishi , Yoshio Doi , Noboru Hoshi
IPC分类号： A61K9/48 , A61K47/00
CPC分类号： A61K9/4858 , A61K9/4816 , A61K9/485
摘要： The invention provides a novel means for overcoming the problem of undue and irregular delay in the exhibition of the effect of medicine when a patient is administrated with an enterosoluble hard-capsulated medicament. The unexpected discovery that the key parameter ruling the smooth transfer of an enterosoluble capsule from the stomach to the intestinal canals is the overall specific gravity of the capsule has led to the establishment of the invention which proposes an enterosoluble hard-capsulated medicament having an overall specific gravity of at least 1.05 or, preferably, at least 1.10.
摘要翻译：本发明提供了一种新颖的手段，克服了当患者服用肠溶性硬封闭药物时，展示药物效果的不当和不规律延误的问题。意外的发现是，将肠溶胶囊从胃平滑转移到肠道的关键参数是胶囊的总比重导致本发明的建立，其提出了具有总体特异性的肠溶性硬封闭药物重力至少为1.05，优选为至少1.10。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式